Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Pepe
    Member
    • Mar 2009
    • 30

    #1

    Tophat --segment-length

    Hi,

    I hope the developers see this post. I'll post it here so I can attach a figure that will help me making my point.
    I think I've found a bug in Tophat (v1.0.13).

    Reads that are spliced in segments that match multiples of the --segment-length parameter automatically are assigned a skipped region of the size of --segment-length.
    No mismatches are assigned to the read and counts as valid, (which would be if the skipped region was assigned the real value)

    In the figure attached (obtained from IGV, colored positions are mismatches to the reference) , there are clearly 5 reads that are wrongly spliced (I only allow 2 mismatches to the reference), the --segment-length parameter was set to 20. The cigar strings and NM tags for those 5 reads are:
    40M20N20M, NM:i:0
    40M20N20M, NM:i:0
    20M20N40M, NM:i:0
    20M20N40M, NM:i:0

    If I align the reads setting --segment-length to 25 I will find many reads with cigar: 25M25N50M and 50M25N25M,
    for --segment-length = 21: 21M21N42M and 42M21N21M

    I hope this helps.
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...